Delivery Order SPE2DR25D2101-SPE2DR26F47ZZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,773.72 to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Lenvima 18 mg daily dose in a 90-count package. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of February 4, 2026, to be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order valued at $10,773.72 to AmerisourceBergen Drug Corp for Lenvima 10 mg daily dose (30-count supply) with a completion date of February 6, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031....
- On January 14, 2026, the Defense Logistics Agency awarded a $43,094.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Lenvima 4 mg capsules (30-count units). This is a non-set-aside competitive award with an ultimate completion date of February 5, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with parent company Cencora, Inc. (doing business as AmerisourceBergen) holding the underlying...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Lenvima 14 mg daily dose (60-count units) with a contract value of $10,223.24 and a firm fixed price structure. This delivery order represents a non-set-aside, competitively awarded contract with an ultimate completion date of December 1, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $10,773.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Lenvima 18 mg daily dose medication in 90-count units. The contract, which is not set-aside and carries an ultimate completion date of January 27, 2026, represents a competitively awarded purchase under AmerisourceBergen's broader pharmaceutical supply framework with the federal government. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,773.72 for Lenvima 14 mg daily dose (60-count supply) on December 23, 2025, with an ultimate completion date of January 15, 2026. This firm fixed-price contract represents a non-set-aside competitive award and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $10,773.72 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Lenvima 18 mg daily dose in a 90-day supply quantity. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled from AmerisourceBergen's...
- The Defense Logistics Agency awarded a $9,910.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Lenvima 14 mg daily dose in a 60-count quantity. This non-set-aside contract was awarded on May 6, 2025, with an ultimate completion date of May 28, 2025. The order will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Lenvima is a targeted cancer therapy used in the treatment of various malignancies, reflecting the Defense Logistics...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,773.72 by the Defense Logistics Agency on January 23, 2026, for the supply of LENVIMA 14 mg daily dose (60 count). This firm fixed-price, non-set-aside contract is scheduled for completion by February 13, 2026. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $10,773.72 delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of LENVIMA 14 mg daily dose tablets in a 60-count package. The contract is a firm fixed price delivery order with an ultimate completion date of January 21, 2026, and represents a non-competitive, competitively awarded transaction. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location....
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F47ZZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on February 4, 2026, for the supply of Lenvima 18 mg daily dose in a 90-count package at a firm fixed price of $10,773.72, with an ultimate completion date of February 26, 2026. This non-competitive delivery order represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. The contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the supply of specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement serving military and veteran healthcare systems. Lenvima is a prescription oncology medication, consistent with the company's portfolio of pharmaceutical deliveries across multiple therapeutic domains. The delivery order will be fulfilled at the company's Conshohocken facility, leveraging the established infrastructure and capabilities demonstrated through the parent company's substantial indefinite delivery contract with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.8k | 2/3/26 |